FMR LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 262 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
FMR LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$85,961,499
-77.7%
2,259,766
-46.5%
0.01%
-78.1%
Q2 2023$384,951,742
+37.3%
4,225,595
-0.6%
0.03%
+146.2%
Q1 2023$280,387,648
+271.3%
4,250,874
+191.1%
0.01%
+62.5%
Q4 2022$75,505,029
-24.3%
1,460,163
-0.0%
0.01%
-20.0%
Q3 2022$99,729,000
+58.8%
1,460,164
+5.2%
0.01%
+66.7%
Q2 2022$62,784,000
-11.6%
1,388,427
-0.7%
0.01%0.0%
Q1 2022$71,012,000
-7.0%
1,397,592
-13.5%
0.01%0.0%
Q4 2021$76,351,000
+43.4%
1,614,8590.0%0.01%
+50.0%
Q3 2021$53,226,000
-42.8%
1,614,859
+9.8%
0.00%
-42.9%
Q2 2021$92,978,000
+33.7%
1,471,165
-9.3%
0.01%
+16.7%
Q1 2021$69,568,000
+6.7%
1,621,252
+42.2%
0.01%0.0%
Q4 2020$65,192,000
+705.8%
1,139,726
+325.1%
0.01%
+500.0%
Q3 2020$8,090,000
-50.3%
268,134
-46.2%
0.00%
-50.0%
Q2 2020$16,272,000
+17.1%
498,222
-3.9%
0.00%0.0%
Q1 2020$13,892,000
-15.9%
518,534
-3.9%
0.00%0.0%
Q4 2019$16,517,000
+83.7%
539,434
+44.6%
0.00%
+100.0%
Q3 2019$8,989,000
-2.3%
373,134
+2.8%
0.00%0.0%
Q2 2019$9,202,000
+29.8%
363,134
-0.1%
0.00%0.0%
Q1 2019$7,087,000
+14.4%
363,428
-22.6%
0.00%0.0%
Q4 2018$6,197,000
-38.6%
469,828
-17.2%
0.00%0.0%
Q3 2018$10,087,000
-65.9%
567,328
-57.8%
0.00%
-66.7%
Q2 2018$29,549,000
+33.9%
1,343,140
+34.6%
0.00%0.0%
Q1 2018$22,061,000
+234.5%
997,764
+228.3%
0.00%
+200.0%
Q4 2017$6,595,000303,9170.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders